Antibodies Incorporated
When Antibodies Incorporated opened its doors in 1962, antibody-related research was in its nascence. Founder Jim Hillman, having received a Ph.D. in pharmacology from the University of Minnesota, arrived at UC Davis to complete post-doctoral work in immunochemistry, which he had studied while working at the California Institute of Technology (Caltech) under Dan Campbell, a pioneer of the field.
Antibodies Inc are now part of the Janel Group.
Neuromabs
NeuroMab monoclonal antibodies are validated for biochemical and immunohistochemical applications in mammalian brain samples, including immunoblotting, immunohistochemistry and array tomography. For perspectives on application-specific antibody validation see Taussig et al., New Biotech 45:1, 2018. PubMed.
For information on NeuroMab monoclonal antibody validation see Gong et al., New Biotech 33:551, 2016. PubMed. See detailed sample preparation and labeling protocols used for NeuroMab monoclonal antibody validation.
See publications list for peer-reviewed papers showing data obtained with NeuroMabs, now over >3000 publications!
Alpaca-derived nanobodies as part of the antibody ‘toolbox’
Will Fry, Ph.D., goes over some of the unique traits that set Camelid antibodies apart from those derived from traditional hosts and make them perfect for many projects.